|
|
|
|
| LEADER |
01102naa a2200313 i 4500 |
| 001 |
NSK01000957119 |
| 003 |
HR-ZaNSK |
| 005 |
20171113145848.0 |
| 007 |
ta |
| 008 |
170228s2014 ci | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)000957119
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b hrv
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 616
|2 MRF 2011.
|
| 080 |
1 |
|
|a 615
|2 MRF 2011.
|
| 100 |
1 |
|
|a Vazdar, Ljubica
|
| 245 |
1 |
0 |
|a HER2 positive breast cancer in elderly patients :
|b tumor biology and specificities of systemic treatment /
|c Ljubica Vazdar, Mirjana Pavlović, Robert Šeparović, Tajana Silovski.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 32 jed.
|
| 504 |
|
|
|a Sažetak
|
| 653 |
|
0 |
|a Karcinom dojke
|a Dob bolesnica
|a HER-2 protein
|a Kemoterapija
|a Citostatici
|a Trastuzumab
|a Srčana funkcija
|a Usporedba
|
| 700 |
1 |
|
|a Pavlović, Mirjana,
|c liječnica
|
| 700 |
1 |
|
|a Šeparović, Robert
|
| 700 |
1 |
|
|a Stančerić, Tajana
|
| 773 |
0 |
|
|t Libri oncologici
|x 0300-8142
|g 42 (2014), 1/3 ; str. 99-105
|w nsk.(HR-ZaNSK)000011357
|
| 981 |
|
|
|b B11/14
|
| 998 |
|
|
|a sapo1702
|